
Pharma Pulse 4/5/24: Patient with Pig Kidney Goes Home, Combining AI and Market Access & more
The latest news for pharma industry insiders.
Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?
Market shares have fallen for CVS, UnitedHealth Group and more following the announcement.
Richard Slayman, 62, is the first patient to receive a kidney from a genetically modified pig. Two weeks after the procedure, he was well enough to be discharged, doctors said.
Monthly healthcare membership now provides consumers with savings of up to 90% at more than 1,200 Publix locations
In an interview with Pharmaceutical Executive, Fady Boctor, MBA discusses both the recent availability of Opill as an over-the-counter contraceptive and shares his insights on the future of OTC contraceptives.
Part 1: https://lnkd.in/dDKw_eZN
Part 2: https://lnkd.in/dVafVYjA
#PetrosPharma #OTCmarkets #contraceptives
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





